Carillon Tower Advisers’s Teladoc Health TDOC Stock Holding History

Carillon Tower Advisers’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$60.4M	Buy	302,088 +87,697	+41%	+$17.8M	0.37%	85
2020 Q3	$47M	Sell	214,391 -417,229	-66%	-$88.4M	0.63%	20
2020 Q2	$121M	Buy	631,620 +106,187	+20%	+$18.6M	0.93%	11
2020 Q1	$85.4M	Sell	525,433 -5,000	-0.9%	-$582K	0.84%	17
2019 Q4	$44.4M	Sell	530,433 -199,082	-27%	-$15.2M	0.3%	115
2019 Q3	$49.4M	Hold	729,515	–	–	0.34%	96
2019 Q2	$48.4M	Hold	729,515	–	–	0.33%	102
2019 Q1	$40.6M	Hold	729,515	–	–	0.29%	129
2018 Q4	$36.2M	Sell	729,515 -628,220	-46%	-$38.4M	0.31%	116
2018 Q3	$117M	Hold	1,357,735	–	–	0.84%	9
2018 Q2	$78.8M	Sell	1,357,735 -305,754	-18%	-$14.9M	0.62%	26
2018 Q1	$64M	Hold	1,663,489	–	–	0.5%	45
2017 Q4	$58M	Buy	+1,663,489	New	+$55.2M	0.62%	39

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Carillon Tower Advisers's TDOC Position: Q4 2020 in Review

Carillon Tower Advisers increased its Teladoc Health (TDOC) stake by 41% in Q4 2020, buying an estimated $17.8M and bringing the position to 302,088 shares worth $60.4M. The position accounts for 0.37% of the portfolio, ranked #85.

Carillon Tower Advisers first reported a position in TDOC in Q4 2017 and has held it in 13 quarters since. The position peaked at $121M in Q2 2020. 901 funds tracked by Wall St. Rank hold TDOC as of Q4 2020.

Carillon Tower Advisers held 302,088 shares of Teladoc Health worth $60.4M as of Q4 2020.
Carillon Tower Advisers bought 87,697 Teladoc Health shares in Q4 2020, an estimated $17.8M.
Teladoc Health made up 0.37% of Carillon Tower Advisers's portfolio in Q4 2020, its #85 holding.
Carillon Tower Advisers first reported a position in Teladoc Health in Q4 2017 and has held it in 13 quarters since.
Carillon Tower Advisers's Teladoc Health position peaked at $121M in Q2 2020.
901 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.